• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞对以不同时间依赖性模式释放的骨形态发生蛋白-2(BMP-2)和胰岛素样生长因子-I(IGF-I)的反应。

Cell responses to BMP-2 and IGF-I released with different time-dependent profiles.

作者信息

Raiche A T, Puleo D A

机构信息

Center for Biomedical Engineering, University of Kentucky, Lexington, Kentucky 40506-0070, USA.

出版信息

J Biomed Mater Res A. 2004 May 1;69(2):342-50. doi: 10.1002/jbm.a.30006.

DOI:10.1002/jbm.a.30006
PMID:15058007
Abstract

During wound healing, growth factors are expressed in time-dependent amounts. Constant delivery of biomolecules, however, is often used to influence cell and tissue behavior. In the present studies, a crosslinked gelatin-coating system was used to deliver bone morphogenetic protein 2 (BMP-2) or insulin-like growth factor (IGF-I) to three types of mesenchymal cells with three temporally varying release profiles. The "early" delivery profile released most of the growth factor within the first 2 days. The "pseudo-zero-order" profile approximated constant rate of delivery for about 5 days. The "late" delivery profile released most of the growth factor after about 5 days. Early delivery of IGF-I had the greatest effect on mitogenesis of SaOS-2 human osteosarcoma cells with a secondary effect noted nearly 5 days after delivery was completed. Late delivery of BMP-2 resulted in greatest alkaline phosphatase (AP) activity in mouse pluripotent C3H10T1/2 cells. Rat bone marrow stromal cells (BMCs) responded to all delivery profiles of BMP-2, with the duration of elevated AP activity increasing as the amount of BMP-2 delivered increased. In addition to an early increase in AP activity, late release also stimulated BMCs over a longer portion of the culture period. BMCs responded similarly to SaOS-2 cells when seeded on early IGF-I delivery coatings, increasing AP activity after delivery had ended. Overall, these studies further show the importance of delivery profile, specifically the characteristics of time and concentration, on cell and tissue responses.

摘要

在伤口愈合过程中,生长因子会按时间依赖性量表达。然而,生物分子的持续递送常被用于影响细胞和组织行为。在本研究中,一种交联明胶涂层系统被用于以三种随时间变化的释放模式将骨形态发生蛋白2(BMP - 2)或胰岛素样生长因子(IGF - I)递送至三种间充质细胞类型。“早期”释放模式在最初2天内释放大部分生长因子。“准零级”模式在约5天内近似恒定的递送速率。“晚期”释放模式在约5天后释放大部分生长因子。IGF - I的早期递送对SaOS - 2人骨肉瘤细胞的有丝分裂产生的影响最大,在递送完成近5天后还观察到次要影响。BMP - 2的晚期递送在小鼠多能C3H10T1/2细胞中导致最大的碱性磷酸酶(AP)活性。大鼠骨髓基质细胞(BMCs)对BMP - 2的所有递送模式均有反应,随着BMP - 2递送量的增加,AP活性升高的持续时间也增加。除了AP活性早期增加外,晚期释放还在较长的培养期内刺激BMCs。当接种在早期IGF - I递送涂层上时,BMCs对SaOS - 2细胞的反应类似,在递送结束后AP活性增加。总体而言,这些研究进一步表明了递送模式的重要性,特别是时间和浓度特征对细胞和组织反应的影响。

相似文献

1
Cell responses to BMP-2 and IGF-I released with different time-dependent profiles.细胞对以不同时间依赖性模式释放的骨形态发生蛋白-2(BMP-2)和胰岛素样生长因子-I(IGF-I)的反应。
J Biomed Mater Res A. 2004 May 1;69(2):342-50. doi: 10.1002/jbm.a.30006.
2
Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering.将一种顺序性骨形态发生蛋白-2/骨形态发生蛋白-7递送系统整合到用于骨组织工程的壳聚糖基支架中。
Biomaterials. 2009 Jul;30(21):3551-9. doi: 10.1016/j.biomaterials.2009.03.024. Epub 2009 Apr 9.
3
In vitro effects of combined and sequential delivery of two bone growth factors.两种骨生长因子联合及序贯递送的体外效应
Biomaterials. 2004 Feb;25(4):677-85. doi: 10.1016/s0142-9612(03)00564-7.
4
Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.骨形态发生蛋白-2修饰的丝素蛋白膜诱导人骨髓基质细胞的成骨分化。
J Biomed Mater Res A. 2004 Dec 1;71(3):528-37. doi: 10.1002/jbm.a.30186.
5
Effect of low intensity pulsed ultrasound and BMP-2 on rat bone marrow stromal cell gene expression.低强度脉冲超声和骨形态发生蛋白-2对大鼠骨髓基质细胞基因表达的影响。
J Orthop Res. 2005 May;23(3):646-52. doi: 10.1016/j.orthres.2004.09.007.
6
Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.从肝素共轭聚(L-乳酸-共-乙醇酸)支架释放的骨形态发生蛋白-2对异位骨形成的增强作用。
Biomaterials. 2007 Jun;28(17):2763-71. doi: 10.1016/j.biomaterials.2007.02.023. Epub 2007 Mar 12.
7
Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6.骨形态发生蛋白-2或-6介导的干细胞基因成骨分化
J Orthop Res. 2006 Jun;24(6):1279-91. doi: 10.1002/jor.20068.
8
Effect of growth factors on cell proliferation, matrix deposition, and morphology of human nasal septal chondrocytes cultured in monolayer.生长因子对单层培养的人鼻中隔软骨细胞增殖、基质沉积及形态的影响。
Laryngoscope. 2005 Sep;115(9):1553-60. doi: 10.1097/01.MLG.0000175541.31131.A5.
9
Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2.用骨形态发生蛋白2对多层DNA涂层进行功能化修饰。
J Control Release. 2006 Jun 12;113(1):63-72. doi: 10.1016/j.jconrel.2006.03.016. Epub 2006 Apr 5.
10
In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments.大鼠骨髓细胞对碱性成纤维细胞生长因子(bFGF)和骨形态发生蛋白-2(BMP-2)处理的体外成骨反应。
Clin Orthop Relat Res. 2006 Feb;443:113-23. doi: 10.1097/01.blo.0000200236.84189.87.

引用本文的文献

1
3D-Bioprinting Strategies Based on In Situ Bone-Healing Mechanism for Vascularized Bone Tissue Engineering.基于原位骨愈合机制的血管化骨组织工程3D生物打印策略
Micromachines (Basel). 2021 Mar 8;12(3):287. doi: 10.3390/mi12030287.
2
A systems biology approach to studying the molecular mechanisms of osteoblastic differentiation under cytokine combination treatment.一种用于研究细胞因子联合治疗下成骨细胞分化分子机制的系统生物学方法。
NPJ Regen Med. 2017 Mar 10;2:5. doi: 10.1038/s41536-017-0009-0. eCollection 2017.
3
Optimal Control of One-dimensional Cellular Uptake in Tissue Engineering.
组织工程中一维细胞摄取的最优控制
Optim Control Appl Methods. 2013 Nov;34(6):680-695. doi: 10.1002/oca.2047.
4
Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.控制释放策略在骨、软骨和骨软骨工程中的应用 - 第一部分:天然组织愈合的重现和输送系统设计的变量。
Tissue Eng Part B Rev. 2013 Aug;19(4):308-26. doi: 10.1089/ten.TEB.2012.0138. Epub 2013 Feb 19.
5
Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.控制释放策略在骨、软骨和骨软骨工程中的应用 - 第二部分:从单一到多种生物活性因子传递的演变所面临的挑战。
Tissue Eng Part B Rev. 2013 Aug;19(4):327-52. doi: 10.1089/ten.TEB.2012.0727. Epub 2013 Jan 30.
6
pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute.聚(甲基丙烯酸羟乙酯)-n-羟基琥珀酰亚胺共聚物(pHEMA-nHA)包封和递送万古霉素和 rhBMP-2,增强其作为骨移植替代物的作用。
Clin Orthop Relat Res. 2013 Aug;471(8):2540-7. doi: 10.1007/s11999-012-2644-5.
7
Effect of coadministration of vancomycin and BMP-2 on cocultured Staphylococcus aureus and W-20-17 mouse bone marrow stromal cells in vitro.万古霉素和 BMP-2 共给药对体外共培养金黄色葡萄球菌和 W-20-17 鼠骨髓基质细胞的影响。
Antimicrob Agents Chemother. 2012 Jul;56(7):3776-84. doi: 10.1128/AAC.00114-12. Epub 2012 May 7.
8
Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation.壳聚糖凝胶联合明胶微球序贯递送 BMP-2 和 IGF-1 促进早期成骨细胞分化。
Acta Biomater. 2012 May;8(5):1768-77. doi: 10.1016/j.actbio.2012.01.009. Epub 2012 Jan 18.
9
Comparison of bone morphogenetic protein-2 and osteoactivin for mesenchymal cell differentiation: effects of bolus and continuous administration.比较骨形态发生蛋白-2 和骨激活素对间充质细胞分化的作用:单次大剂量给药和持续给药的影响。
J Cell Physiol. 2011 Nov;226(11):2943-52. doi: 10.1002/jcp.22639.
10
Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.BMP - 2/7、RANKL和四环素从弹性骨传导性骨替代物FlexBone中实现持续且局部的体外释放。
J Orthop Res. 2009 Oct;27(10):1306-11. doi: 10.1002/jor.20890.